Literature DB >> 8529095

Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia.

K Odunsi1, G Terry, L Ho, J Bell, J Cuzick, T S Ganesan.   

Abstract

BACKGROUND: Cervical intraepithelial neoplasia (CIN) and cervical cancer have been shown to be strongly associated with infection by human papillomavirus (HPV). However, other factors may be contributory in the progression from normal epithelium to CIN and cervical cancer, since not all women with HPV infection develop disease. Recently, it was demonstrated that there is a high risk for cervical cancer and CIN in women with HLA DQB1 * 03 (RR = 7.1, p < 0.0009) (1). Subsequent reports have been conflicting, due to sample size, genetic heterogeneity and differences in the techniques employed for the detection of HLA DQB1 * 03.
MATERIALS AND METHODS: DNA from cervical smears of 178 women with CIN and 420 controls with normal cervical cytology was analyzed by polymerase chain reaction (PCR) with type-specific primers for HPV 16, 18, 31, and 33. The DNA from test and control samples were also analyzed by a novel PCR technique, which mutates the first base of codon 40 (DQ alleles) from T to G to create an artificial restriction site for an enzyme Mlu I that distinguish DQB1 * 03 from other alleles and are confirmed by digestion of amplified DNA with Mlu I. Further analysis of individual DQB1 * 03 alleles was performed using PCR and allele-specific primers.
RESULTS: One hundred forty-four (34%) out of 420 controls (all HPV 16, 18, 31, or 33 negative and normal cytology), 37/66 (56%) of CIN I and 72/112 (64%) of CIN III were positive for DQB1 * 03 (trend test, p < 0.001, chi 2 = 37.3). A significant association was observed between DQB1 * 03 and CIN (odds ratio 3.03; 95% CI 2.11-3.45). Of women with CIN, 131/178 (73.5%) had HPV (types 16, 18, 31, or 33) infection. There was a significant association between DQB1 * 03 and presence of HPV (odds ratio 3.43; 95% CI 2.25-5.10). Homozygosity for DQB1 * 03 was more strongly associated with CIN than heterozygosity (odds ratios 4.0 and 2.63, respectively); and for the presence of HPV (odds ratio 4.47; 95% CI 2.58-7.77). HLA DQB1 * 0301 was the most strongly associated allele with CIN and HPV (odds ratios 2.53 and 2.63, respectively).
CONCLUSIONS: HLA DQB1 * 03 is associated significantly with CIN and may be permissive for HPV infection. Further analysis of class II HLA typing in CIN is necessary to evaluate this association.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529095      PMCID: PMC2229948     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  31 in total

Review 1.  What is the basis for HLA-DQ associations with autoimmune disease?

Authors:  D M Altmann; D Sansom; S G Marsh
Journal:  Immunol Today       Date:  1991-08

2.  Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis.

Authors:  E Mellins; M Woelfel; D Pious
Journal:  Hum Immunol       Date:  1987-03       Impact factor: 2.850

3.  Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

Authors:  T Sasazuki; Y Kohno; I Iwamoto; M Tanimura; S Naito
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

4.  Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women.

Authors:  L Gregoire; W D Lawrence; D Kukuruga; A B Eisenbrey; W D Lancaster
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

5.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Authors:  L P Chen; E K Thomas; S L Hu; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 6.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

7.  High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3.

Authors:  R Wank; C Thomssen
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

8.  Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted.

Authors:  P Salgame; J Convit; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

10.  Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression.

Authors:  H zur Hausen
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

View more
  6 in total

1.  Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis.

Authors:  Yong-Ning Xin; Zhong-Hua Lin; Xiang-Jun Jiang; Shu-Hui Zhan; Quan-Jiang Dong; Qing Wang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL).

Authors:  Elias Orouji; Jalil Tavakkol Afshari; Zahra Badiee; Abbas Shirdel; Afrouz Alipour
Journal:  Int J Hematol       Date:  2012-03-21       Impact factor: 2.490

Review 3.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

4.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

Review 5.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

6.  Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Authors:  Mahboobeh Safaeian; Lisa G Johnson; Kai Yu; Sophia S Wang; Patti E Gravitt; John A Hansen; Mary Carrington; Stephen M Schwartz; Xiaojiang Gao; Allan Hildesheim; Margaret M Madeleine
Journal:  Front Oncol       Date:  2014-06-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.